Literature DB >> 8754851

Cellular transformation and malignancy induced by ras require c-jun.

R Johnson1, B Spiegelman, D Hanahan, R Wisdom.   

Abstract

ras is an important oncogene in experimental animals and humans. In addition, activated ras proteins are potent inducers of the transcription factor AP-1, which is composed of heterodimeric complexes of Fos and Jun proteins. Together with the fact that deregulated expression of some AP-1 proteins can cause neoplastic transformation, this finding suggests that AP-1 may function as a critical ras effector. We have tested this hypothesis directly by analyzing the response to activated ras in cells that harbor a null mutation in the c-jun gene. The transcriptional response of AP-1-responsive genes to activated ras is severely impaired in c-jun null fibroblasts. Compared with wild-type cells, the c-jun null cells lack many characteristics of ras transformation, including loss of contact inhibition, anchorage independence, and tumorigenicity in nude mice; these properties are restored by forced expression of c-jun. Rare tumorigenic variants of ras-expressing c-jun null fibroblasts do arise. Analysis of these variants reveals a consistent restoration of AP-1 activity. The results provide genetic evidence that c-jun is a crucial effector for transformation by activated ras proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8754851      PMCID: PMC231449          DOI: 10.1128/MCB.16.8.4504

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

Authors:  M I Diamond; J N Miner; S K Yoshinaga; K R Yamamoto
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

2.  Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences.

Authors:  T J Bos; F S Monteclaro; F Mitsunobu; A R Ball; C H Chang; T Nishimura; P K Vogt
Journal:  Genes Dev       Date:  1990-10       Impact factor: 11.361

3.  Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.

Authors:  B Binétruy; T Smeal; M Karin
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

4.  Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase.

Authors:  Q Hu; A Klippel; A J Muslin; W J Fantl; L T Williams
Journal:  Science       Date:  1995-04-07       Impact factor: 47.728

5.  Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

Authors:  C Jonat; H J Rahmsdorf; K K Park; A C Cato; S Gebel; H Ponta; P Herrlich
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

6.  Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor.

Authors:  R Schüle; P Rangarajan; S Kliewer; L J Ransone; J Bolado; N Yang; I M Verma; R M Evans
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

Authors:  H F Yang-Yen; J C Chambard; Y L Sun; T Smeal; T J Schmidt; J Drouin; M Karin
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

8.  c-fos is required for malignant progression of skin tumors.

Authors:  E Saez; S E Rutberg; E Mueller; H Oppenheim; J Smoluk; S H Yuspa; B M Spiegelman
Journal:  Cell       Date:  1995-09-08       Impact factor: 41.582

9.  Multiple Ras functions can contribute to mammalian cell transformation.

Authors:  M A White; C Nicolette; A Minden; A Polverino; L Van Aelst; M Karin; M H Wigler
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

10.  Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes.

Authors:  E Hu; E Mueller; S Oliviero; V E Papaioannou; R Johnson; B M Spiegelman
Journal:  EMBO J       Date:  1994-07-01       Impact factor: 11.598

View more
  85 in total

1.  Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.

Authors:  S Leppä; M Eriksson; R Saffrich; W Ansorge; D Bohmann
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

2.  JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

Authors:  Yan-Fen Hu; Rong Li
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

3.  Identification of a co-activator that links growth factor signalling to c-Jun/AP-1 activation.

Authors:  Clare C Davies; Atanu Chakraborty; Filippo Cipriani; Katharina Haigh; Jody J Haigh; Axel Behrens
Journal:  Nat Cell Biol       Date:  2010-09-19       Impact factor: 28.824

Review 4.  Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.

Authors:  Jiao Zhang; Yan-Hua Chen; Qun Lu
Journal:  Future Oncol       Date:  2010-04       Impact factor: 3.404

5.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

6.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

7.  Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.

Authors:  J K Westwick; Q T Lambert; G J Clark; M Symons; L Van Aelst; R G Pestell; C J Der
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

8.  Pleiotropic action of AP-1 in v-Src-transformed cells.

Authors:  Lizhen Wang; Natalie A Rodrigues; Ying Wu; Bart M Maslikowski; Nishi Singh; Samantha Lacroix; Pierre-André Bédard
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

9.  Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN).

Authors:  Zao-zhong Su; Seok-Geun Lee; Luni Emdad; Irina V Lebdeva; Pankaj Gupta; Kristoffer Valerie; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-12       Impact factor: 11.205

10.  Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse.

Authors:  Joseph C Cheng; Aiping Bai; Thomas H Beckham; S Tucker Marrison; Caroline L Yount; Katherine Young; Ping Lu; Anne M Bartlett; Bill X Wu; Barry J Keane; Kent E Armeson; David T Marshall; Thomas E Keane; Michael T Smith; E Ellen Jones; Richard R Drake; Alicja Bielawska; James S Norris; Xiang Liu
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.